Commit To Purchase EyePoint Pharmaceuticals At $12.50, Earn 61% Annualized Using Options
April 19, 2024 at 11:33 AM EDT
Investors eyeing a purchase of EyePoint Pharmaceuticals Inc (EYPT) stock, but tentative about paying the going market price of $17.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $12.50 strike, which has a bid at the time of this writing of $1.90..